The global antithrombin market size was valued at USD 876.92 billion in 2025 and is expected to reach USD 1256.64 billion by 2033, at a CAGR of 4.60% during the forecast period
The market growth is largely fueled by the increasing prevalence of thrombotic disorders, rising awareness about anticoagulant therapies, and advancements in biopharmaceutical manufacturing, leading to greater adoption of antithrombin solutions in both clinical and hospital settings
Furthermore, growing demand for safe and effective blood clot prevention therapies, coupled with increasing healthcare expenditure and expanding patient access to specialized treatments, is accelerating the uptake of Antithrombin solutions, thereby significantly boosting the industry's growth